Glenmark Life Sciencesâ Rs 1,600-cr IPO may open next week Glenmark Life Sciencesâ IPO comprises a fresh issue of Rs 1,160 crore and a sale of 7.3 million shares by promoter Glenmark Pharmaceuticals Glenmark Life Sciences filed for an updated DRHP last week BusinessToday.In Updated Jul 19, 2021, 9:44 AM IST Glenmark Life Sciences (GLS), a unit of Glenmark Pharmaceuticals is among a long list of companies queuing for an initial public offering. The company filed for an updated draft red herring prospectus (DRHP) last week. GLSâ Rs 1,600-crore IPO is likely to be launched later in July. While Glemark has not officially said anything on the matter, sources told The Economic Times that they are aiming to hit the primary markets next week.